NCT00555737

Brief Summary

The purpose of this study is to determine how well capsule endoscopy identifies changes in the small bowel mucosa of celiac disease patients.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2003

Typical duration for all trials

Geographic Reach
3 countries

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2003

Completed
3.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2007

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

November 8, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 9, 2007

Completed
Last Updated

July 31, 2019

Status Verified

November 1, 2007

First QC Date

November 8, 2007

Last Update Submit

July 29, 2019

Conditions

Keywords

Celiac DiseaseCapsule Endoscopysmall Bowel Disease

Outcome Measures

Primary Outcomes (1)

  • The number of findings identified during the capsule endoscopy or upper GI endoscopy procedure, and which were considered by the investigator as related to the gluten sensitive enteropathy origin

    within 14 days of enrollment

Secondary Outcomes (1)

  • Longitudinal extent of villous changes in the small bowel will be evaluated.

    within 14 days of enrollment

Interventions

Given® Diagnostic system with Pillcam SB

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

clinic paitnets with known Gluten sensitivity (Celaic).

You may qualify if:

  • Patient age is 18 years or older
  • Patient agrees to sign the Informed Consent Form
  • Patient has positive celiac serology or negative celiac serology + IgA deficiency and suffers from one or more of the following symptoms and/or abdominal biochemical values:
  • Chronic diarrhea
  • Weight loss
  • Abdominal cramps
  • History of spontaneous abortion
  • Iron deficiency anemia
  • Osteoporosis
  • Infertility
  • Hypoalbuminaemia
  • Low cholesterol
  • Low prothrombin activity

You may not qualify if:

  • Patient is known or is suspected to suffer from intestinal obstruction.
  • Patient has a cardiac pacemaker or other electro-medical device.
  • Patient suffers from severe swallowing disorder or Zenker's diverticulum
  • Patient has any condition, which precludes compliance with study and/or device instructions.
  • Female patient is pregnant
  • Patient suffers from life threatening conditions
  • Patient is currently participating in another clinical study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

University of Massachusetts Memorial Medical Center

Worcester, Massachusetts, 01655, United States

Location

University of Tampere Medical School

Tampere, Finland

Location

Ospedale Maggiore - Policlinico

Milan, 20122, Italy

Location

Universita Cattolica del Sacro Cuore

Rome, Italy

Location

San Giovanni A.S. Hospital

Torino, Italy

Location

MeSH Terms

Conditions

Celiac Disease

Interventions

Capsule Endoscopy

Condition Hierarchy (Ancestors)

Malabsorption SyndromesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Endoscopy, GastrointestinalEndoscopy, Digestive SystemEndoscopyDiagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Roberto de Franchis, MD, Prof.

    Ospedale Maggiore - Policlinico, Milano, Italy

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

November 8, 2007

First Posted

November 9, 2007

Study Start

November 1, 2003

Study Completion

July 1, 2007

Last Updated

July 31, 2019

Record last verified: 2007-11

Locations